What to look for in a partner to support biosimilar initiatives
This article looks at some of the trends in biosimilars, including three key errors you need to avoid. Particularly, as it pertains to underestimating your risk management plan.
Ian Kovacs, Head of QPPV & Safety Consulting at PAREXEL answers five key questions about the key role of a QPPV and why you should consider outsourcing.
Read this article to find out how engaging with local affiliates from day one is essential to understand any country-specific differences in market requirements.
